The post-release period in a drug’s development—properly known as the “postmarketing surveillance” period, is one of immense importance. Additional testing and data gathering are conducted to detail the real effects that a drug has on the wide population using the product, with the findings then used to refine messaging about potential safety issues, and potentially whether the drug can continue to be sold. In Canada, postmarketing surveillance is managed by the Marketed Health Products Directorate (MHPD), which oversees and conducts a number of important functions required to be performed after a drug’s release. Want to learn a bit more about.. READ MORE »
